Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hemophilia
MedTech
‘Neural tourniquet’ could hold the key to stopping hemorrhaging
An ear-based wearable device that taps the body’s longest cranial nerve boosts blood clotting in what could be a new way of treating severe bleeding.
Ben Adams
Jul 14, 2026 8:45am
Metagenomi sheds 25% of workforce, including CEO
Nov 12, 2025 6:30am
Novo adds pediatric data to bulging bag of hemophilia A evidence
Feb 7, 2025 5:28am
Pfizer crashes Sangamo's stock by ending hem A gene therapy pact
Jan 2, 2025 6:08am
Roche culls ph. 3 Spark gene therapy in hemophilia
Dec 16, 2024 12:24pm
Centessa drops hemophilia B drug following Pfizer’s Hympavzi win
Nov 12, 2024 9:45am
